News

Kuros Biosciences Reports Results for First Half 2023

Schlieren (Zurich), Switzerland, August 9, 2023 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, today reported a 148% growth in MagnetOs direct sales in the first six months of 2023. The enrollment of patients in the Phase II spine study for Fibrin-PTH was...

read more

GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine

Schlieren (Zurich), 20 July 2023 - LimmaTech Biologics AG (“LimmaTech Bio”), a clinicalstage biotech company developing vaccines for the prevention of life-threatening diseases, signed an in-license agreement with GlaxoSmithKline Biologicals SA (LSE/NYSE: GSK) enabling LimmaTech Bio to further develop and commercialize a quadrivalent bioconjugate vaccine candidate for shigellosis that GSK...

read more

Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial

Schlieren (Zurich), Switzerland, July 13, 2023 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today the completion of enrollment in the STRUCTURE trial, which is investigating the safety and efficacy of Fibrin-PTH (KUR-113) in single-level transforaminal lumbar interbody fusion (TLIF) procedures in...

read more

Schlieren BBQ sponsored by LubioScience

  When? Thursday, July 06, 2023, 11:30 - 14:00 Where? Between the Roche Tower and Wagi S Fancy a sausage hot off the grill? Or a spicy veggie option? Then join us for our BBQ event in Schlieren and meet the Lubio team! Ready for the party? Register here no later than June 30. Registration is mandatory...

read more